Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-216-8 | CAS number: 7790-62-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: This study was selected as the key study because the information provided for the hazard endpoint is sufficient for the purpose of classification and labelling and/or risk assessment.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- 13-Week Subchronic Oral Toxicity Study of Ammonium Sulfate in Rats
- Author:
- Takagi H, Onodera H, Yun L, Yasuhara K, Koujitani T, Mitsumori K, and Hirose M
- Year:
- 1 999
- Bibliographic source:
- Kokuritsu Iyuakuhin Shokuhin Eisei Kenkyusho Hokoku [Bull. Natl. Health Sci.], 117:108-114
Materials and methods
- Principles of method if other than guideline:
- A 13-week subchronic oral toxicity study was performed in male and female rats
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Ammonium sulphate
- EC Number:
- 231-984-1
- EC Name:
- Ammonium sulphate
- Cas Number:
- 7783-20-2
- IUPAC Name:
- diammonium sulfate
- Details on test material:
- - Purity: Not reported
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344/DuCrj
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Japan
- Age at study initiation: ~6 weeks
- Weight at study initiation: not reported
- Fasting period before study: No
- Housing: 5per plastic cage using soft chips as bedding
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): not reported
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24±1°C
- Humidity (%): 55±5%
- Air changes (per hr): 18
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- DIET PREPARATION: Food was stored at room temperature until used. Stability was checked for one week at room temperature.
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 13 Weeks
- Frequency of treatment:
- Continuously in the diet
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0.38, 0.75, 1.5, 3%
Basis:
nominal in diet
- Remarks:
- Doses / Concentrations:
220, 441, 886, 1792 mg/kg/day (males); 239, 484, 961, 1975 mg/kg/day (females)
Basis:
actual ingested
- No. of animals per sex per dose:
- 10/sex/dose
- Control animals:
- yes, plain diet
- Details on study design:
- - Dose selection rationale: In a 2-week preliminary study, female F344 rats were administered 5% of the test substance in diet. Significant weight gain suppression and diarrhoea were observed when compared to controls. Based on these findings, the doses selected for the 13-week subchronic toxicity study were 0.38, 0.75, 1.5, and 3%.
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily
- Cage side observations checked : Mortality, behaviour
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
- Time schedule for examinations: Weekly
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes
- Time schedule: Weekly
FOOD EFFICIENCY: No
WATER CONSUMPTION AND COMPOUND INTAKE: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: Blood was collected from the aorta abdominalis post mortem (during necropsy)
- Anaesthetic used for blood collection: No
- Animals fasted: No data
- How many animals: All
- Parameters examined: erythrocyte count, haemoglobin, haematocrit, mean cell volume, mean corpuscular haemoglobin content, mean corpuscular haemoglobin concentration, platelet count, leukocyte count
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: Blood was collected from the aorta abdominalis post mortem (during necropsy)
- Animals fasted: No data
- How many animals: All
- Parameters examined: total protein, albumin/globulin ratio, albumin, total cholesterol, urea nitrogen, sodium, chloride, potassium, calcium, inorganic phosphorus, glutamat-oxaloacetic transaminase, glutamate-pyruvat transaminase, alkaline phosphatase
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
Brain, heart, lungs, liver, kidneys, adrenals, spleen, testes, and thymus were weighed. In addition to these, other main organs were fixed (10% neutral buffered formalin), sectioned, stained (haematoxyline and eosin) and examined histologically. - Statistics:
- Variance in data for body weights, haematology, serum biochemistry, and organ weights was checked for homogeneity by the Bartlett test. When the data were homogeneous, one-way analysis of variance (ANOVA) was used. When a significant difference between groups was observed, the Dunnett method was used when the number of animals per group was equal or the Schiff method was used when the number of animals per group was unequal. When dispersion was not equal, the Kruskal-Wallis test was applied and when statistically significant differences were indicated, Dunnett's or Schiff test was employed.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- CLINICAL SIGNS AND MORTALITY: No mortality was observed. Diarrhoea was observed in the males at 3% starting at week 1 continuing throughout the study.
BODY WEIGHT AND WEIGHT GAIN: Body weight gain was significantly decreased in 3% males when compared with controls.
Final mean body weights were significantly decreased in males receiving 0.38%, 1.5% and 3%, and significantly increased in females of the same groups when compared with controls. The changes in the 0.38% group were not dose-related.
FOOD CONSUMPTION: There were no significant differences between the groups for both males and females.
HAEMATOLOGY and CLINICAL CHEMISTRY: The following, statistically significant and dose-related changes were observed:
- decreased leukocyte count (3% males)
- decreased erythrocyte count, haemoglobin, decreased haematocrit, and platelet count (3% females).
- increased mean corpuscular haemoglobin content and mean corpuscular haemoglobin concentration (3% females)
The same changes in haematological parameters were also observed in 1.5% males and females; however, these changes were not dose-related.
Blood serum analysis revealed some statistically significant alterations; however, there was no dose-response. These changes were not considered biologically significant, as they were within the limits of background data and no anomalies were observed in the haematopoietic organs.
ORGAN WEIGHTS: Increased absolute and relative spleen weights (males only) and kidney weights (males and females) were observed at 3%. Relative testis weights were increased at all dose levels and relative liver weight was increased in females at all doses. However, no dose-related trend was observed. Therefore, the authors did not consider these findings adverse or indicative of obvious test substance toxicity.
PATHOLOGY: Histological examination revealed myofibrosis cordis (3% males), basophilia of the renal tubuli (3% males and females), and melanosis of the spleen (3% males and females). However, the incidence of these findings was not statistically significantly different from control.
According to the authors, with exception of the diarrhoea observed in high dose males, none of these observations was considered to indicate obvious toxicity of the test substance.
Effect levels
open allclose all
- Dose descriptor:
- NOEL
- Effect level:
- 1.5 other: % (886 mg/kg bw/day)
- Sex:
- male
- Basis for effect level:
- other: based on diarrhoea observed in 3% males
- Dose descriptor:
- NOEL
- Effect level:
- 3 other: % (1975 mg/kg/day)
- Sex:
- female
- Basis for effect level:
- other: no adverse effects at highest dose tested
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- NOAEL: 1.5% (886 mg/kg/day) for males and 3% (1975 mg/kg/day) for females
This study and the conclusions which are drawn from it fulfil the quality criteria (validity, reliability, repeatability). - Executive summary:
A 13-week subchronic oral toxicity study of ammonium sulphate was performed in both sexes of F344 rats by feeding them a CRF-1 powder diet containing concentrations of 0.38, 0.75, 1.5, and 3.0% of the test substance. A control group was fed plain diet. Rats were randomly divided into 5 groups each consisting of 10 males and 10 females. The mean daily doses were 220, 441, 886, 1792 mg/kg bw/day for males, and 239, 484, 961, 1975 mg/kg bw/day for females. Male animals in the 3% group exhibited diarrhoea during the administration period. No changes indicating obvious ammonium sulphate toxicity were observed in the body weights, organ weights, haematological, serum biochemical, or histopathological examinations. Based on these results, the NOEL (no-observed-effect level) of ammonium sulphate for F344 rats was judged to be 1.5% in males (886 mg/kg/day) and 3% in females (1975 mg/kg/day).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.